TDO2 Was Downregulated in Hepatocellular Carcinoma and Inhibited Cell Proliferation by Upregulating the Expression of p21 and p27

Figure 1

The mRNA expression of TDO2 in HCC samples from TCGA, according to UALCAN analysis. (a) The mRNA expression of TDO2 across different cancers in TCGA. (b) The mRNA expression of TDO2 in liver cancer stratified by sample type. (c) The expression of TDO2 in liver cancer stratified by tumor grade. (d) The expression of TDO2 in liver cancer stratified by cancer stage. (e) The expression of TDO2 in liver cancer stratified by nodal metastasis status.

(a)

(b)

(c)

(d)

(e)